Salvatore Petta

Research interests

Publications

• Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

  JAMA · 2024 · https://doi.org/10.1001/jama.2024.1447

• EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.05.025

• Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

  Gut · 2021 · https://doi.org/10.1136/gutjnl-2021-324243

• Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.04.044

• Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease

  Clinical Gastroenterology and Hepatology · 2020 · https://doi.org/10.1016/j.cgh.2020.06.045

• Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.11.024

• Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

  Science Translational Medicine · 2020 · https://doi.org/10.1126/scitranslmed.aba4448

• Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.04.003

• Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

  Hepatology · 2019 · https://doi.org/10.1002/hep.30908

• Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.03.027

• Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

  Journal of Hepatology · 2018 · https://doi.org/10.1016/j.jhep.2018.05.036

• Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation

  Transplantation · 2018 · https://doi.org/10.1097/tp.0000000000002484

• Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

  Gastroenterology · 2018 · https://doi.org/10.1053/j.gastro.2018.04.008

• Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

  Gastroenterology · 2018 · https://doi.org/10.1053/j.gastro.2018.04.008

• MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

  Scientific Reports · 2017 · https://doi.org/10.1038/s41598-017-04991-0

• Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

  Journal of Internal Medicine · 2017 · https://doi.org/10.1111/joim.12719

• Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity

  Clinical Gastroenterology and Hepatology · 2017 · https://doi.org/10.1016/j.cgh.2017.04.045

• AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

  Digestive and Liver Disease · 2017 · https://doi.org/10.1016/j.dld.2017.01.147

• The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

  Gastroenterology · 2016 · https://doi.org/10.1053/j.gastro.2016.01.032

• Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease

  Alimentary Pharmacology & Therapeutics · 2016 · https://doi.org/10.1111/apt.13889

• Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

  Hepatology · 2016 · https://doi.org/10.1002/hep.28843

• Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

  The American Journal of Gastroenterology · 2016 · https://doi.org/10.1038/ajg.2016.453

• Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies

  Gastroenterology · 2015 · https://doi.org/10.1053/j.gastro.2015.09.007

• Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice

  Hepatology · 2015 · https://doi.org/10.1002/hep.28392

• The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

  Hepatology · 2015 · https://doi.org/10.1002/hep.27844

• Statin use and non-alcoholic steatohepatitis in at risk individuals

  Journal of Hepatology · 2015 · https://doi.org/10.1016/j.jhep.2015.05.006

• Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

  Hepatology · 2014 · https://doi.org/10.1002/hep.27490

• Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver disease

  Journal of Hepatology · 2014 · https://doi.org/10.1016/j.jhep.2014.11.030

• Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

  Gastroenterology · 2012 · https://doi.org/10.1053/j.gastro.2012.07.018

• Comparison of Transient Elastography and Acoustic Radiation Force Impulse for Non-Invasive Staging of Liver Fibrosis in Patients With Chronic Hepatitis C

  The American Journal of Gastroenterology · 2011 · https://doi.org/10.1038/ajg.2011.341

• Non-alcoholic fatty liver disease pathogenesis: The present and the future

  Digestive and Liver Disease · 2009 · https://doi.org/10.1016/j.dld.2009.01.004

• Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C†

  Hepatology · 2009 · https://doi.org/10.1002/hep.23489

Current projects

No projects listed.